AcmeLabs

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

AcmeLabs - overview

Established

1971

Location

Vancouver, British Columbia, Canada

Primary Industry

Chemicals

About

AcmeLabs is a prominent provider of analytical testing and certification solutions, specializing in the mining and exploration sectors, delivering precision and compliance through a comprehensive range of laboratory services. AcmeLabs, founded in 1971, operates in Vancouver, Canada, providing specialized analytical services for the mining industry. In February 2012, Bureau Veritas acquired AcmeLabs, enhancing its portfolio in mining laboratory services. The founder's history is not specified, and there are no known subsidiaries or prior pivots in business strategy.


AcmeLabs specializes in Mining Laboratory Services, offering a wide array of analytical testing, inspection, and certification solutions tailored for the Exploration and Mining sectors. Core offerings include fire assays for precious metals, inductively coupled plasma (ICP) analyses, and ICP-mass spectrometry. These services support quality sample preparation and accurate result generation, assisting clients in compliance with regulatory standards and effective resource management. The company serves a diverse customer base, including mining corporations, exploration companies, and environmental agencies in North America, with strategically located laboratories across 27 countries globally.


In 2011, AcmeLabs generated revenue of USD 72. 99 mn through its Mining Laboratory Services, engaging in contractual agreements with clients for analytical testing and certification. The company operates primarily on a B2B basis, providing ongoing analytical services tailored to specific project needs, with various testing options that ensure compliance with regulatory standards. AcmeLabs, under Bureau Veritas, aims to expand its service offerings by introducing new analytical testing products designed for enhanced resource management, with a targeted launch by 2014.


The company's strategy includes geographic expansion into emerging markets within South America and Africa, anticipated to commence by the end of 2015. Recent funding from the acquisition will support these initiatives, allowing for investment in new technologies and infrastructure to bolster operational capabilities.


Current Investors

Bureau Veritas Group

Primary Industry

Chemicals

Sub Industries

Chemicals, Nanomaterials

Website

www.acmelab.com

Company Stage

Add-on

Total Amount Raised

Subscriber access only

AcmeLabs - financials

Fiscal Year EndedJan 01, 2011
Revenue (USD)-
% Revenue Growth (YoY)-
EBITDA (USD)-
Operating Income (USD)-
Operating Margin-
% EBITDA Margin-
NET Income (USD)-
% Net Margin-

AcmeLabs - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedAcmeLabs-

Displaying 1 - 1 of 1

AcmeLabs - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.